Revenue Cycle Management Market Size is Forecasted to Reach US$ 135.12 Billion by 2027

According to Precedence Research, during the forecast period of 2020 to 2027, the global revenue cycle management market is estimated to develop at a compound annual growth rate (CAGR) of 12.2%. The global revenue cycle management market was valued at USD 65.96 billion in 2021, and it is predicted to exceed USD 135.12 billion by 2027. The study investigates several elements and their consequences on the growth of the revenue cycle management market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1065

Growth Factor

The growth of revenue cycle management (RCM) market is mainly driven by government initiatives to support the adoption of RCM solutions paired with rising need of process improvements in healthcare sectors. In addition, growing complexity in revenue cycle, old technology, and limitations in staffing qualified employees is also predicted to propel the demand for revenue cycle management (RCM) market in years to come. On the contrary, high costs associated with revenue cycle management deployment and shortage of skilled IT professionals may limit the growth of market in years to come. Even so, increasing market for outsourced RCM solutions is expected to open up plenty of opportunities for market participant in near future.

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1065

This report focuses on revenue cycle management market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall revenue cycle management market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Report Highlights

• Favorable regulatory compliance, increasing need of process improvements in healthcare sectors and rising spending on healthcare are the major factors estimated to drive the global revenue cycle management market in years to come.
• Standalone type segment is expected to lose its revenue share in coming years owing to increasing adoption of integrated type revenue cycle management systems by healthcare professional and hospitals.
• In 2019, On-premise deployment segment of global revenue cycle management market was valued around USD 28,912 million. The growth of this segment is primarily driven by better data security and protecting unauthorized access of user’s server or workstation
• Asia Pacific is predicted to be the fastest growing region for global revenue cycle management market and is likely to grow at a CAGR of 15.8% in forecast period.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of revenue cycle management, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of revenue cycle management has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the revenue cycle management market.

Some of the prominent players in the revenue cycle management market include:

• Cerner Corporation
• McKesson Corporation
• Quest Diagnostics Incorporated
• Allscripts Healthcare Solutions
• Athenahealth
• CareCloud
• Emdeon
• The SSI Group Inc
• GE Healthcare
• Eclinicalworks
• Meditech
• Epic Systems
• Conifer Health Solutions
• Gebbs Healthcare Solutions
• Constellation Software
• Experian PLC
• NextGen Healthcare Information System LLC

Segments Covered in the Report

By Deployment

• Web-Based
• On-Premise
• Cloud-Based

By Offering

• Services
• Software

By Type

• Standalone
• Integrated

By End User

• Hospitals
• Physician Offices
• Diagnostic Laboratories
• Others (Pharmacies, academic medical centers etc.)

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Revenue Cycle Management Market, By Deployment

7.1. Revenue Cycle Management Market, by Deployment Type, 2020-2027
7.1.1. Web-Based
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. On-Premise
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Cloud-Based
7.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Revenue Cycle Management Market, By Offering

8.1. Revenue Cycle Management Market, by Offering, 2020-2027
8.1.1. Services
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Revenue Cycle Management Market, By Type

9.1. Revenue Cycle Management Market, by Type, 2020-2027
9.1.1. Standalone
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Integrated
9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Revenue Cycle Management Market, By End-User

10.1. Revenue Cycle Management Market, by End-User, 2020-2027
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Physician Offices
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Diagnostic Laboratories
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Others (Pharmacies, academic medical centers etc.)
10.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Revenue Cycle Management Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.1.2. Market Revenue and Forecast, by Offering (2016-2027)
11.1.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.4. Market Revenue and Forecast, by End-User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End-User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End-User (2016-2027)

Chapter 12. Company Profiles

12.1. Cerner Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. McKesson Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Quest Diagnostics Incorporated
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Allscripts Healthcare Solutions
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Athenahealth
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CareCloud
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Emdeon
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. The SSI Group Inc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. GE Healthcare
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Eclinicalworks
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Meditech
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Epic Systems
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Conifer Health Solutions
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Gebbs Healthcare Solutions
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Constellation Software
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
12.16. Experian PLC
12.16.1. Company Overview
12.16.2. Product Offerings
12.16.3. Financial Performance
12.16.4. Recent Initiatives
12.17. NextGen Healthcare Information System LLC
12.17.1. Company Overview
12.17.2. Product Offerings
12.17.3. Financial Performance
12.17.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1065

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com